Welcome to EvolveGene
Discover a new era in healthcare at EvolveGene, where we're dedicated to unlocking the potential of your genetic code. Our mission is simple: to empower you with personalized genetic insights for a healthier life.
At EvolveGene we're more than just a clinic; we're your partners in health. Our expert team is committed to providing cutting-edge genetic testing and counseling services tailored to your unique needs.
Services We Offer:
- NIPT (Non-Invasive Prenatal Testing)
- PGT (Preimplantation Genetic Testing)
- Parental Genetic Testing
- WES (Whole Exome Sequencing)
- WGS (Whole Genome Sequencing)
Initial Consultation
Family History
Education
Decision-Makings
Our Clinic
Our expertise encompasses a range of services, including Non-Invasive Prenatal Testing (NIPT), Preimplantation Genetic Diagnosis (PGD), Parental Genetic Testing, and Whole Exome Sequencing (WES). We provide Gene Map testing tailored for couples with familial connections, ensuring a comprehensive understanding of their genetic map and potential health considerations.
Why Choose EvolveGene
Our commitment is to provide personalized genetic insights, ensuring a journey towards lasting health. What sets us apart is not only our cutting-edge genetic testing and counseling services but also the unique advantage of our lab located outside Jordan, adding a distinctive edge to our offerings.
-
Expertise
-
Personalization
Our Services
Explore a spectrum of advanced genetic services tailored to your family's health and well-being.
PGT ( Preimplantation Genetic Test)
Preimplantation Genetic Diagnosis (PGD) is a specialized genetic testing procedure employed during in vitro fertilization (IVF) to examine embryos for genetic abnormalities before implantation. With an accuracy rate of over 98%, PGD allows for the identification of chromosomal abnormalities, single gene disorders, or other genetic conditions in embryos. This not only increases the likelihood of a successful pregnancy but significantly reduces the risk of passing on genetic disorders to offspring. PGD has become an essential tool in assisted reproductive technology, providing couples with the ability to make informed choices for a healthier family.
| Test | Sample | TAT |
|---|---|---|
| Pre PGTM | Blood Sample | 3-4 weeks |
| PGT-M & PGT-A | Embryo`s Biopsy | 3-4 weeks |
| Test | Sample | TAT |
|---|---|---|
| PGT-A Unlimited number of embryos screening for 24 chromosomes abnormalities | Embryo`s Biopsy Day 3/5 | 48 hours |
| Price per embryo screening for 24 chromosomes abnormalities | Embryo`s Biopsy Day 3/5 | 48 hours |
| 5 chromosomes abnormalities Unlimited number of EMBs | Embryo`s Biopsy Day 3/5 | 48 hours |
| Price per embryo 5 chromosomes abnormalities | Embryo`s Biopsy Day 3/5 | 48 hours |
| PGT-SR Unlimited number of embryos | Embryo`s Biopsy Day 5 | 7 days |
| POC product of conception/CVS/AF | ||
|---|---|---|
| Karyotype | Identify chromosomal abnormalities | |
NIPT (Non-Invasive Prenatal Testing)
Non-Invasive Prenatal Testing (NIPT) is a revolutionary genetic screening tool designed to assess the risk of chromosomal abnormalities in a developing fetus. This minimally invasive procedure requires a simple blood draw from the expectant mother, analyzing cell-free DNA present in the maternal bloodstream. NIPT boasts an impressive accuracy rate, with studies indicating detection rates exceeding 99% for common trisomies such as Down syndrome. This high level of accuracy allows for early detection, often as early as 9-10 weeks into pregnancy. NIPT is a safe and reliable option for expectant parents seeking comprehensive genetic information to make informed decisions about their pregnancy.
| Test | Sample | TAT |
|---|---|---|
| NIPT (21,18,13 and chromomal aneuploides in X and Y) | Blood Sample | 7-10 days |
| NIPT 24 | Blood Sample | 7-10 days |
GPD (Genomic Precision Diagnosis)
Genomic precision diagnosis is an advanced medical approach that analyzes an individual's unique genetic makeup at the genomic level. By identifying specific genetic variations associated with medical conditions, this technique offers highly accurate and personalized insights into disease risk, prognosis, and potential treatments. Going beyond traditional diagnostics, genomic precision diagnosis enables healthcare professionals to tailor interventions with unprecedented precision, paving the way for more effective and personalized medical care.
| Test | Sample | TAT |
|---|---|---|
| One-person Whole Exome Sequencing: 23000 genes | Blood Sample/CVS/AF/POC | 30 working days |
| Parents Whole Exome Sequencing (father and mother) | Blood Sample | 30 working days |
| Trio-Whole Exome sequencing (father, mother, and the affected child) | Blood Sample | 30 working days |
| Whole genome sequencing | Blood Sample | 60 working days |
| One-person Microarray | Blood Sample | 30 working days |
| Two-persons Microarray | Blood Sample | 30 working days |
| Carrier testing Target mutation | Blood Sample | 30 working days |
| Karyotype | Blood Sample | 3-4 weeks |
| Y-microdeletion | Blood Sample | 2 weeks |
| Gene sequencing | Blood Sample | 3-4 weeks |
Prenatal Genetic Testing:
Parental Genetic Testing plays a crucial role in understanding the hereditary components within families. By examining the genetic makeup of parents, we can assess the risk of passing on specific genetic conditions to their children. This proactive approach empowers families with crucial information for family planning, with testing accuracy exceeding 99% for certain conditions. Parental Genetic Testing is particularly valuable for those with a family history of genetic disorders, enabling informed decision-making to ensure the health and well-being of future generations.
| Test | Sample | TAT |
|---|---|---|
| Prenatal diagnosis (One mutation) collected from the mother | CVS/AMNIO/MATERNAL BLOOD | 2-3 weeks |
| Prenatal diagnosis (Two mutations) Blood sample should be collected from mother | CVS/AMNIO/MATERNAL BLOOD | 2-3 weeks |
| Prenatal: Whole exome sequencing | CVS/AMNIO/MATERNAL BLOOD | 30 working days |
Cancer Gene Panel:
Micro-Onco Hereditary Cancer Panels represent an advanced and comprehensive approach to genetic testing, specifically tailored to identify hereditary cancer risks. These panels utilize state-of-the-art technology to analyze a multitude of genetic markers associated with various types of cancers. By focusing on micro-level details within the genome, these panels provide intricate insights into an individual's genetic predisposition to certain cancers.
Learn More :
Hereditary Cnace Panlesr Somatic Cnacer Panles| Test | NUMBER OF GENES | STUDY MATERIAL |
|---|---|---|
| Prostate Cancer Panel | 14 Genes | EDTA Blood |
| Fanconi Anemia Panel | 18 Genes | EDTA Blood |
| Micro-Screen Cancer Panel | 275 Genes | EDTA Blood |
| Breast Cancer Panel | 93 Genes | EDTA Blood, FFPE |
| Colon Cancer Panel | 71 Genes | EDTA Blood, FFPE |
| Myeloid Neoplasia Panel | 141 Genes | EDTA Blood, Bone Marrow |
| Lung Cancer Panel | 72 Genes | EDTA Blood, FFPE |
| Micro-HRR Panel | 15 Genes | FFPE, EDTA Blood |
Our Partners
What Our Patients Say About Us
The outstanding and compassionate efforts of the medical team had a profound and positive impact on my mental well-being. Thanks to their exceptional and remarkable dedication, I was able to overcome the critical phase, relying on the mercy of Allah. We express our gratitude, appreciation, and full respect to this brilliant medical team and to all the healthcare teams at EvolveGene.
Dedicated staff with a spirit of care and excellent professional services make patients, family members, and companions feel as if they are at home. The clinic remains clean and is regularly inspected by the staff. Overall, the EvolveGene was the optimal choice for addressing my issue..
We'd Love to Hear From You
Your feedback is invaluable to us. Share your thoughts, and let's make your experience even better!
GET IN Touch
Reach out to us – we're here to assist and eager to connect with you!